Jul. 19 at 8:17 PM
Insider buying alert?
$ELV enters a valuation reset zone.
$ELV is trading at a valuation level worth watching, with a forward P/E of 12.62 and P/S of just 0.4 as healthcare sentiment remains pressured.
Recent insider purchases:
President & CEO Boudreaux Gail:
$1,002,230
Jul 17 '26:
$1,002,230
Director PERU RAMIRO G:
$366,050
Jul 17 '26:
$366,050
Technically, healthcare leaders often create long-term opportunities when sentiment and valuation compress together.
Both executives and directors buying with their own capital is a signal worth monitoring. The market may focus on short-term headlines, but fundamentals eventually drive price.
The first reaction is rarely the final one.
